LJ-Bodhi
4 주 전
Ummmmm can you explain this basic concept to us? How was the product proven to be effective before the official human trial started? Did they just find some homeless folks to give the product to and then hope for the best? Well, Jimmy from the underpass lost 7 pounds last week so the stuff must work? And he didn't die. It's safe!
You want to know what's basic? Go to Amazon who sells products and then read the reviews. That is the basic concept of selling a product first, and then asking the public to weigh in about what they think of it after purchase.
In the alternate reality, one sells the unregulated supplement first, and THEN gets the clinical results to determine whether it is effective and safe....but they were already told how effective and safe it was....before they bought it....but they are supposed to be the test group to determine safety and effectiveness..... but it was already proven to totally work before the clinical test.....but they need to participate in the test to see if it works.....yep, about as basic as a circle....a circular argument. As always, good luck and buy more!! As I said, if she runs, I'll hop on the train.
Just don't call people stupid. It's better to basically imply someone is stupid with lots of sarcasm. Basic stuff really.
LJ-Bodhi
4 주 전
Check the FAQ page of the Zeranovia website. Can't buy the product. The "clinical study" requires participants to PAY $149/month to participate. Typically, clinical studies pay or reimburse participants for time and expenses, and rarely do participants pay themselves. As this article explains, product production costs are the ethical exception if asking participants to pay. One must ask themselves if BDPT is paying $149 to produce a month supply of this product and/or whether someone paying for supplements might skew any data results. Shady way to do things, but BDPT has a history:
https://pmc.ncbi.nlm.nih.gov/articles/PMC8133344/
Wynovia has no product or trial yet, just a coming soon banner on that website.
Xcellara is $227/bottle with no information on quantity or dosage, so folks need to buy it blind and hope for the best. No clinical trial for that one other than the claim that a double blind study occurred.
Very expensive products with no track record, but anything can happen on the OTC. Good Luck out there folks!
LJ-Bodhi
1 월 전
I acknowledge it sounds like bashing, but the reality and timeline should be considered here. This Keener guy was running a home restoration company in Hawaii. In less than a year of coming to Bio, he's found a holy grail weight loss supplement? Just something to consider, wouldn't you agree? This supplement business is totally unregulated so folks can make all sorts of outlandish claims. The stock might move, but the products have severe competition. Walk into any health store and look at all the supplements. Then go to Amazon. Tough, tough market to crack and everyone claims to have discovered the newest hoodad.
Just one person's perspective to share on this board. Disagreement is fine by me.
Giovanni
2 월 전
Thanks
BioAdaptives Welcomes UFC Senior Executive Reed Harris to Its Board of Advisors
February 06, 2025 at 09:25 am EST
Share
LAS VEGAS, Feb. 06, 2025 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives Inc. (OTC: BDPT), a leading biotechnology company focused on innovative health and wellness solutions, proudly announces the appointment of Reed Harris to its Board of Advisors. Harris brings decades of experience in leadership, athlete development and business management, and an unparalleled commitment to innovation and excellence in professional and personal endeavors.
Reed Harris, the Senior Vice President of Athlete Development and Marketing at the Ultimate Fighting Championship (UFC) in Las Vegas, has a distinguished career spanning over 40 years. He blends expertise in martial arts, business development and charity work. His life and career reflect a dedication to discipline, growth and giving back to the community.
Harris founded World Extreme Cagefighting (WEC), one of the leading MMA promotions in the U.S. and internationally broadcasted in Canada, Brazil, Mexico and Australia. He sold WEC to the UFC in 2006 and continued to run the organization until its merger with the UFC in 2012.
Harris will work closely with BioAdaptives' marketing department to introduce several new products, including Xcellera, the stem cell activator proven in randomized, double-blind, placebo-controlled human clinical trials to increase circulating stem cells on average by 268.8% in 28 days. It is beneficial for tissue repair, anti-aging, immune and cardiovascular support and more.
Jim Keener, CEO of BioAdaptives, Inc., said: "We are excited to welcome Reed Harris to our Board of Advisors. Reed’s exceptional leadership, business acumen and dedication to athlete development and community service align perfectly with our mission to deliver innovative health and wellness solutions. His deep experience building and managing successful organizations and his passion for helping others makes him an invaluable asset to BioAdaptives as we expand our reach and impact."
Reed Harris’s addition to the Board of Advisors reflects BioAdaptives’ commitment to strengthening its leadership team and advancing its mission of improving lives through cutting-edge biotechnology and holistic health solutions.
About BioAdaptives, Inc.
BioAdaptives, Inc. (OTC: BDPT) is a leading innovator in the health and wellness industry, dedicated to developing and marketing nutraceutical and wellness products that harness the power of natural ingredients and cutting-edge science. Our mission is to improve the quality of life for our customers by offering products that support optimal health and vitality.
For more information about Xcellara™ Stem Cell Activator and other BioAdaptives products, please visit our website at www.bioadaptives.com.
Contact Information: